Search Results

FIH Use of Artio Medical’s Amplifi Vein Dilation System Completed

January 27, 2021—Artio Medical, Inc. announced that it has successfully completed the first-in-human use of its Amplifi vein dilation system, which prepares a vessel for arteriovenous fistula (AVF) creation.

Artio Medical’s Amplifi Vein Dilation System Evaluated in First-in-Human Trial

July 29, 2021—Artio Medical, Inc. announced it has completed enrollment in its first-in-human study evaluating the company’s Amplifi vein dilation system, which is intended to dilate and prepare veins before arteriovenous fistula (AVF) surgery.

Enrollment Begins for Study of Bluegrass Vascular's Surfacer Inside-Out Access Catheter

December 9, 2011—Bluegrass Vascular Technologies, Inc. (Lexington, KY) announced the commencement of patient enrollment in the first clinical study of its Surfacer inside-out access catheter system.

Obvius Robotics’ Certa Access System Used in FIH Procedures

June 8, 2023—Obvius Robotics, Inc. announced the completion of the first-in-human (FIH) cases with the company’s Certa percutaneous access system.

First-in-Man Studies Completed for Medeon Biodesign's XPro Large-Bore Vascular Closure Device

November 3, 2015—Medeon Biodesign, Inc., a Taiwan medical device company, announced the completion of first-in-man studies for its XPro suture-mediated vascular closure device for closure of 8–21-F femoral access sites.

Merit Medical Announces US Availability of Bluegrass Vascular’s Surfacer System

September 1, 2020—Merit Medical Systems, Inc. announced the availability of Bluegrass Vascular Technologies’ Surfacer Inside-Out access catheter system in the United States.